Want to see HEWA full AI Analyst Report?
HEWA Stock Chart & Stats
$0.12
<$0.01(7.37%)
At close: 4:00 PM EDT
$0.12
<$0.01(7.37%)
Day’s Range― - ―
52-Week Range$0.08 - $0.18
Previous CloseN/A
Volume5.00K
Average Volume (3M)1.13K
Market Cap
$5.84M
Enterprise Value$9.88
Total Cash (Recent Filing)$1.07M
Total Debt (Recent Filing)$3.52M
Price to Earnings (P/E)―
Beta-0.44
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding57,190,910
10 Day Avg. Volume684
30 Day Avg. Volume1,126
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)-1.88
Price to Sales (P/S)0.13
P/FCF Ratio5.83
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Gross MarginThe improved gross margin shows stronger economics on products sold and could support recovery if prescription volume stabilizes. However, the benefit remains incomplete because the company still reported operating and net losses in the TTM period.
Prior Revenue ExpansionHistorical expansion demonstrates that HealthWarehouse can grow its online pharmacy revenue base when demand and execution align. This provides an operating foundation, although the subsequent TTM decline indicates that growth has not yet become consistent.
Asset Growth And Moderate DebtGrowth in the asset base may support continued pharmacy operations and fulfillment capacity, while moderate absolute debt limits one source of pressure. Nevertheless, negative equity materially weakens the balance-sheet benefit and financial flexibility.
Bears Say
Persistently Negative EquityA persistent equity deficit signals a fragile capital structure and reduces access to flexible financing. It also increases refinancing risk because leverage is elevated relative to the negative equity base, limiting resilience during operating setbacks.
Revenue And Profitability DeteriorationThe sharp TTM revenue contraction and return to losses indicate that demand, reimbursement, or execution pressures are outweighing prior growth. Sustained weakness would limit scale benefits and make it harder to convert improved gross margin into durable earnings.
Inconsistent Cash GenerationNegative recent operating and free cash flow means the pharmacy is not consistently funding its operations internally. Continued cash shortfalls could increase reliance on external financing and compound the risks created by the negative equity position.
HEWA FAQ
What was HealthWarehouse.com Inc’s price range in the past 12 months?
HealthWarehouse.com Inc lowest stock price was $0.08 and its highest was $0.18 in the past 12 months.
What is HealthWarehouse.com Inc’s market cap?
HealthWarehouse.com Inc’s market cap is $5.84M.
When is HealthWarehouse.com Inc’s upcoming earnings report date?
HealthWarehouse.com Inc’s upcoming earnings report date is Nov 18, 2026 which is in 68 days.
How were HealthWarehouse.com Inc’s earnings last quarter?
HealthWarehouse.com Inc released its earnings results on Aug 13, 2026. The company reported -$0.009 earnings per share for the quarter.
Is HealthWarehouse.com Inc overvalued?
According to Wall Street analysts HealthWarehouse.com Inc’s price is currently Overvalued.
Does HealthWarehouse.com Inc pay dividends?
HealthWarehouse.com Inc does not currently pay dividends.
What is HealthWarehouse.com Inc’s EPS estimate?
HealthWarehouse.com Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HealthWarehouse.com Inc have?
HealthWarehouse.com Inc has 57,190,910 shares outstanding.
What happened to HealthWarehouse.com Inc’s price movement after its last earnings report?
HealthWarehouse.com Inc reported an EPS of -$0.009 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of HealthWarehouse.com Inc?
Currently, no hedge funds are holding shares in HEWA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HealthWarehouse.com Inc
HealthWarehouse.com, Inc. functions as a digital and direct-mail pharmaceutical service. Its offerings encompass a broad spectrum of pharmaceutical items, including generic and brand-name prescription drugs, specialized medications for pets, and a variety of over-the-counter remedies and goods. The company serves customers across all 50 U.S. states and the District of Columbia, specifically targeting the market for prescription drugs paid for directly by consumers. Sales are conducted directly to individual consumers via its online platform. Its corporate headquarters are situated in Florence, Kentucky.
Technical Analysis
Petmed Express
―
ENDRA Life Sciences
―
LifeMD
―
Pasithea Therapeutics Corp
―
Heart Test Laboratories, Inc.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors